{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:24:19Z","timestamp":1793413459521,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["965397"],"award-info":[{"award-number":["965397"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000770","name":"University of Manchester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["CTRQQR-2021\/100010"],"award-info":[{"award-number":["CTRQQR-2021\/100010"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C5759\/ A27412"],"award-info":[{"award-number":["C5759\/ A27412"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biomedical Informatics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jbi.2023.104367","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T20:30:51Z","timestamp":1682454651000},"page":"104367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Meta-analysis informed machine learning: Supporting cytokine storm detection during CAR-T cell Therapy"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1604-5097","authenticated-orcid":false,"given":"Alex","family":"Bogatu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Wysocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Wysocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Butterworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f3nal","family":"Landers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Kilgour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4832-7008","authenticated-orcid":false,"given":"Fiona","family":"Thistlethwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"177","key":"10.1016\/j.jbi.2023.104367_b1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"16","key":"10.1016\/j.jbi.2023.104367_b2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor\u2013Modified T cells for acute lymphoid Leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.jbi.2023.104367_b3","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jbi.2023.104367_b4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1200\/JCO.2014.56.2025","article-title":"Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor","volume":"33","author":"Kochenderfer","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"224","key":"10.1016\/j.jbi.2023.104367_b5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19-28z CAR T cell therapy in b cell acute lymphoblastic leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.jbi.2023.104367_b6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jbi.2023.104367_b7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","article-title":"Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy","volume":"22","author":"Morris","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.jbi.2023.104367_b8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/mt.2010.24","article-title":"Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2","volume":"18","author":"Morgan","year":"2010","journal-title":"Mol. Ther.","ISSN":"https:\/\/id.crossref.org\/issn\/1525-0016","issn-type":"print"},{"issue":"8","key":"10.1016\/j.jbi.2023.104367_b9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor\u2013Modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.jbi.2023.104367_b10","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T cells: recognition and management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jbi.2023.104367_b11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s13046-021-02148-6","article-title":"Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies","volume":"40","author":"Xiao","year":"2021","journal-title":"J. Exp. Clin. Cancer Res.","ISSN":"https:\/\/id.crossref.org\/issn\/1756-9966","issn-type":"print"},{"issue":"7","key":"10.1016\/j.jbi.2023.104367_b12","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101085","article-title":"A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory\/relapsed B cell lymphoma","volume":"14","author":"Liu","year":"2021","journal-title":"Transl. Oncol.","ISSN":"https:\/\/id.crossref.org\/issn\/1936-5233","issn-type":"print"},{"issue":"16","key":"10.1016\/j.jbi.2023.104367_b13","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1002\/cam4.3259","article-title":"Phase II trial of co-administration of CD19- and CD20-targeted chimeric antigen receptor t cells for relapsed and refractory diffuse large B cell lymphoma","volume":"9","author":"Sang","year":"2020","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.jbi.2023.104367_b14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nm.4441","article-title":"CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy","volume":"24","author":"Fry","year":"2018","journal-title":"Nat. Med."},{"issue":"13","key":"10.1016\/j.jbi.2023.104367_b15","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1158\/1078-0432.CCR-16-1799","article-title":"Potent anti-leukemia activities of chimeric antigen receptor-modified T Cells against CD19 in Chinese patients with relapsed\/refractory acute lymphocytic leukemia","volume":"23","author":"Hu","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"303","key":"10.1016\/j.jbi.2023.104367_b16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac5415","article-title":"Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia","volume":"7","author":"Porter","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"15","key":"10.1016\/j.jbi.2023.104367_b17","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.3390\/cancers13153912","article-title":"Treatment-related adverse events of chimeric antigen receptor T-cell (CAR T) in clinical trials: A systematic review and meta-analysis","volume":"13","author":"Lei","year":"2021","journal-title":"Cancers","ISSN":"https:\/\/id.crossref.org\/issn\/2072-6694","issn-type":"print"},{"issue":"6","key":"10.1016\/j.jbi.2023.104367_b18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1158\/2159-8290.CD-16-0040","article-title":"Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia","volume":"6","author":"Teachey","year":"2016","journal-title":"Cancer Disc."},{"issue":"6","key":"10.1016\/j.jbi.2023.104367_b19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41591-018-0041-7","article-title":"CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade","volume":"24","author":"Giavridis","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jbi.2023.104367_b20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J. ImmunoTherapy of Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/2051-1426","issn-type":"print"},{"issue":"6","key":"10.1016\/j.jbi.2023.104367_b21","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1189\/jlb.5BT1115-524R","article-title":"At the bedside: Clinical review of chimeric antigen receptor (CAR) T cell therapy for B cell malignancies","volume":"100","author":"Oluwole","year":"2016","journal-title":"J. Leukoc. Biol.","ISSN":"https:\/\/id.crossref.org\/issn\/0741-5400","issn-type":"print"},{"issue":"4","key":"10.1016\/j.jbi.2023.104367_b22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1182\/bloodadvances.2019000952","article-title":"Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management","volume":"4","author":"Pennisi","year":"2020","journal-title":"Blood Advances"},{"issue":"2","key":"10.1016\/j.jbi.2023.104367_b23","doi-asserted-by":"crossref","DOI":"10.1093\/jamiaopen\/ooac053","article-title":"Clinical study applying machine learning to detect a rare disease: results and lessons learned","volume":"5","author":"Hersh","year":"2022","journal-title":"JAMIA Open","ISSN":"https:\/\/id.crossref.org\/issn\/2574-2531","issn-type":"print"},{"issue":"1","key":"10.1016\/j.jbi.2023.104367_b24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13023-020-01424-6","article-title":"The use of machine learning in rare diseases: a scoping review","volume":"15","author":"Schaefer","year":"2020","journal-title":"Orphanet Journal of Rare Diseases","ISSN":"https:\/\/id.crossref.org\/issn\/1750-1172","issn-type":"print"},{"key":"10.1016\/j.jbi.2023.104367_b25","series-title":"Proceedings of ELM-2014 Volume 1","isbn-type":"print","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-3-319-14063-6_6","article-title":"Inductive bias for semi-supervised extreme learning machine","author":"Bisio","year":"2015","ISBN":"https:\/\/id.crossref.org\/isbn\/9783319140636"},{"issue":"3","key":"10.1016\/j.jbi.2023.104367_b26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1109\/TNN.2009.2038695","article-title":"Using unsupervised analysis to constrain generalization bounds for support vector classifiers","volume":"21","author":"Decherchi","year":"2010","journal-title":"IEEE Trans. Neural Netw."},{"key":"10.1016\/j.jbi.2023.104367_b27","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.747612","article-title":"Opportunities and challenges for machine learning in rare diseases","volume":"8","author":"Decherchi","year":"2021","journal-title":"Frontiers in Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/2296-858X","issn-type":"print"},{"issue":"1","key":"10.1016\/j.jbi.2023.104367_b28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1109\/JPROC.2020.3004555","article-title":"A comprehensive survey on transfer learning","volume":"109","author":"Zhuang","year":"2021","journal-title":"Proc. Inst. Radio Eng.","ISSN":"https:\/\/id.crossref.org\/issn\/0018-9219","issn-type":"print"},{"key":"10.1016\/j.jbi.2023.104367_b29","doi-asserted-by":"crossref","unstructured":"Sebastiena C. Wong, et al., Understanding Data Augmentation for Classification: When to Warp?, in: 2016 International Conference on Digital Image Computing: Techniques and Applications (DICTA), 2016, pp. 1\u20136, http:\/\/dx.doi.org\/10.1109\/DICTA.2016.7797091.","DOI":"10.1109\/DICTA.2016.7797091"},{"issue":"10","key":"10.1016\/j.jbi.2023.104367_b30","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1093\/rheumatology\/keab098","article-title":"A distinguishing profile of chemokines, cytokines and biomarkers in the saliva of children with Sj\u00f6gren\u2019s syndrome","volume":"60","author":"Gomeza Hernandez","year":"2021","journal-title":"Rheumatology","ISSN":"https:\/\/id.crossref.org\/issn\/1462-0324","issn-type":"print"},{"key":"10.1016\/j.jbi.2023.104367_b31","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2021.107139","article-title":"Dataset-chemokines, cytokines, and biomarkers in the saliva of children with Sj\u00f6gren\u2019s syndrome","volume":"36","author":"Withanage","year":"2021","journal-title":"Data in Brief","ISSN":"https:\/\/id.crossref.org\/issn\/2352-3409","issn-type":"print"},{"issue":"10","key":"10.1016\/j.jbi.2023.104367_b32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045027","article-title":"Dynamics of a cytokine storm","volume":"7","author":"Yiu","year":"2012","journal-title":"PLoS ONE","ISSN":"https:\/\/id.crossref.org\/issn\/1932-6203","issn-type":"print"},{"issue":"21","key":"10.1016\/j.jbi.2023.104367_b33","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1182\/blood-2017-06-793141","article-title":"Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy","volume":"130","author":"Hay","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jbi.2023.104367_b34","series-title":"Advances in Neural Information Processing Systems 30","first-page":"4765","article-title":"A unified approach to interpreting model predictions","author":"Lundberg","year":"2017"},{"key":"10.1016\/j.jbi.2023.104367_b35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.inffus.2019.12.012","article-title":"Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI","volume":"58","author":"Arrieta","year":"2020","journal-title":"Inf. Fusion"},{"key":"10.1016\/j.jbi.2023.104367_b36","series-title":"Explanation in human-AI systems: A literature meta-review, synopsis of key ideas and publications, and bibliography for explainable AI","author":"Mueller","year":"2019"},{"key":"10.1016\/j.jbi.2023.104367_b37","series-title":"5th IEEE International Conference on Data Science and Advanced Analytics, DSAA 2018, Turin, Italy, October 1-3, 2018","first-page":"80","article-title":"Explaining explanations: An overview of interpretability of machine learning","author":"Gilpin","year":"2018"},{"key":"10.1016\/j.jbi.2023.104367_b38","series-title":"Explanation methods in deep learning: Users, values, concerns and challenges","author":"Ras","year":"2018"},{"key":"10.1016\/j.jbi.2023.104367_b39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dsp.2017.10.011","article-title":"Methods for interpreting and understanding deep neural networks","volume":"73","author":"Montavon","year":"2018","journal-title":"Digit. Signal Process."},{"key":"10.1016\/j.jbi.2023.104367_b40","series-title":"A systematic review of biologically-informed deep learning models for cancer: fundamental trends for encoding and interpreting oncology data","author":"Wysocka","year":"2022"},{"key":"10.1016\/j.jbi.2023.104367_b41","series-title":"The doctor just won\u2019t accept that!","author":"Lipton","year":"2017"},{"key":"10.1016\/j.jbi.2023.104367_b42","series-title":"A survey on explainable artificial intelligence (XAI): towards medical XAI","author":"Tjoa","year":"2019"},{"key":"10.1016\/j.jbi.2023.104367_b43","doi-asserted-by":"crossref","DOI":"10.1016\/j.artint.2022.103839","article-title":"Assessing the communication gap between AI models and healthcare professionals: Explainability, utility and trust in AI-driven clinical decision-making","volume":"316","author":"Wysocki","year":"2023","journal-title":"Artificial Intelligence","ISSN":"https:\/\/id.crossref.org\/issn\/0004-3702","issn-type":"print"},{"key":"10.1016\/j.jbi.2023.104367_b44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1613\/jair.1.13200","article-title":"Explainable deep learning: A field guide for the uninitiated","volume":"73","author":"Ras","year":"2022","journal-title":"J. Artificial Intelligence Res."},{"key":"10.1016\/j.jbi.2023.104367_b45","series-title":"Proceedings of the 34th International Conference on Machine Learning, ICML 2017, Sydney, NSW, Australia, 6-11 August 2017","first-page":"3145","article-title":"Learning important features through propagating activation differences","volume":"70","author":"Shrikumar","year":"2017"},{"key":"10.1016\/j.jbi.2023.104367_b46","series-title":"Proceedings of the 2019 AAAI\/ACM Conference on AI, Ethics, and Society, AIES 2019, Honolulu, HI, USA, January 27-28, 2019","first-page":"123","article-title":"TED: teaching AI to explain its decisions","author":"Hind","year":"2019"},{"issue":"2","key":"10.1016\/j.jbi.2023.104367_b47","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"issue":"2","key":"10.1016\/j.jbi.2023.104367_b48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PPO.0000000000000035","article-title":"Managing cytokine release syndrome associated with novel T cell-engaging therapies","volume":"20","author":"Maude","year":"2014","journal-title":"The Cancer J.","ISSN":"https:\/\/id.crossref.org\/issn\/1528-9117","issn-type":"print"},{"issue":"2","key":"10.1016\/j.jbi.2023.104367_b49","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canlet.2013.10.004","article-title":"Cytokine release syndrome in cancer immunotherapy with chimeric antigen receptor engineered t cells","volume":"343","author":"Xu","year":"2014","journal-title":"Cancer Lett.","ISSN":"https:\/\/id.crossref.org\/issn\/0304-3835","issn-type":"print"},{"issue":"6","key":"10.1016\/j.jbi.2023.104367_b50","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jbi.2023.104367_b51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-018-0653-x","article-title":"Cytokine release syndrome: grading, modeling, and new therapy","volume":"11","author":"Liu","year":"2018","journal-title":"J. Hematol. Oncol.","ISSN":"https:\/\/id.crossref.org\/issn\/1756-8722","issn-type":"print"},{"issue":"8","key":"10.1016\/j.jbi.2023.104367_b52","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ni.3205","article-title":"Interferon-\u03b3 regulates cellular metabolism and mRNA translation to potentiate macrophage activation","volume":"16","author":"Su","year":"2015","journal-title":"Nature Immunol."},{"key":"10.1016\/j.jbi.2023.104367_b53","series-title":"Inference to the best explanation","author":"Lipton","year":"2003"},{"issue":"1","key":"10.1016\/j.jbi.2023.104367_b54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2288-14-137","article-title":"Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints","volume":"14","author":"vana der Ploeg","year":"2014","journal-title":"BMC Med. Res. Methodol.","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2288","issn-type":"print"},{"issue":"1","key":"10.1016\/j.jbi.2023.104367_b55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.jbi.2023.104367_b56","series-title":"Multiple Classifier Systems, First International Workshop, MCS 2000, Cagliari, Italy, June 21-23, 2000, Proceedings","first-page":"1","article-title":"Ensemble methods in machine learning","volume":"1857","author":"Dietterich","year":"2000"},{"key":"10.1016\/j.jbi.2023.104367_b57","first-page":"2825","article-title":"Scikit-learn: Machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"issue":"1","key":"10.1016\/j.jbi.2023.104367_b58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1470-2045(21)00591-X","article-title":"Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial","volume":"23","author":"Jacobson","year":"2022","journal-title":"Lancet Oncol.","ISSN":"https:\/\/id.crossref.org\/issn\/1470-2045","issn-type":"print"},{"issue":"3","key":"10.1016\/j.jbi.2023.104367_b59","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41409-020-01060-5","article-title":"Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy","volume":"56","author":"Hong","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jbi.2023.104367_b60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.611366","article-title":"Characteristics and risk factors of cytokine release syndrome in chimeric antigen receptor T cell treatment","volume":"12","author":"Yan","year":"2021","journal-title":"Front. Immunol.","ISSN":"https:\/\/id.crossref.org\/issn\/1664-3224","issn-type":"print"},{"issue":"3","key":"10.1016\/j.jbi.2023.104367_b61","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/bjh.17673","article-title":"Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B-cell lymphoma","volume":"195","author":"Topp","year":"2021","journal-title":"Br. J.Haematol."},{"issue":"10299","key":"10.1016\/j.jbi.2023.104367_b62","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(21)01222-8","article-title":"KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study","volume":"398","author":"Shah","year":"2021","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"issue":"10","key":"10.1016\/j.jbi.2023.104367_b63","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1016\/S2352-3026(19)30115-2","article-title":"A combination of humanised anti-CD19 and anti-BCMA CAR t cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial","volume":"6","author":"Yan","year":"2019","journal-title":"Lancet Haematol.","ISSN":"https:\/\/id.crossref.org\/issn\/2352-3026","issn-type":"print"},{"issue":"1","key":"10.1016\/j.jbi.2023.104367_b64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13045-018-0681-6","article-title":"A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma","volume":"11","author":"Zhao","year":"2018","journal-title":"J. Hematol. Oncol.","ISSN":"https:\/\/id.crossref.org\/issn\/1756-8722","issn-type":"print"},{"issue":"26","key":"10.1016\/j.jbi.2023.104367_b65","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.jbi.2023.104367_b66","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1200\/JCO.2017.72.8519","article-title":"Durable molecular remissions in chronic lymphocytic leukemia treated with CD19-specific chimeric antigen receptor-modified T cells after failure of Ibrutinib","volume":"35","author":"Turtle","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"95","key":"10.1016\/j.jbi.2023.104367_b67","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci. Transl. Med."}],"container-title":["Journal of Biomedical Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1532046423000886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1532046423000886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:11:10Z","timestamp":1778623870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1532046423000886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":67,"alternative-id":["S1532046423000886"],"URL":"https:\/\/doi.org\/10.1016\/j.jbi.2023.104367","relation":{},"ISSN":["1532-0464"],"issn-type":[{"value":"1532-0464","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis informed machine learning: Supporting cytokine storm detection during CAR-T cell Therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Biomedical Informatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbi.2023.104367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104367"}}